• Treating Cronically III Patients with Transfer Factor

an interview with Carol Ann Ryser, M.D.
 
• Transfer Factor Institute e Transfer Factor Research
• Incontri Scientifici

*
• Controllo di qualità: Gruppi di Controllo

• Home page Torna alla Home page

 
• 4Life Transfer Factor prodotti e componenti

 
• Lavora con noi da casa

*
• *Transfer Factor 

Dr. Ryser: "The diagnosis of a patient is of utmost importance. I perform a series of genetic testing with PCR (Polymer Chain Reaction) that tells me the specific bacteria or virus(es) a patient has. Transfer Factor helps with viral, bacterial, and fungal infections as well as parasites, and supports the immune system while treating the problems a patient has. Regarding what formulas of Transfer Factor I use for different patients, I use the plain Transfer Factor as a general prevention treatment, especially for infections and allergies and for patients with Epstein-Barr, Chronic Fatigue Syndrome." 

Q.:How much Transfer Factor do you typically recommend, and for what kind of patient? 

Dr. Ryser: "For chronically ill patients, including those with chronic sinusitis, and multiple allergies, I recommend six capsules a day, and depending on the severity of their symptoms, I might recommend up to twelve capsules a day.  For children ages 7-12 or 13, depending on weight, I will recommend two capsules a day, to be taken at bedtime. 

When a patient is beginning to get sick and is coming down with a fever, I will have them take two capsules every 2-3 hours, for 24 hours, and that usually knocks the virus "off its socks," so to speak. This dosage of Transfer Factor can nip a fever in the bud, by supporting the immune system’s natural killer cells. 

I also treat fibromyalgia patients with Transfer Factor. I believe that fibromyalgia is most commonly caused by infections, including bacteria, yeast, and parasites. For chronically ill patients dealing with multiple infections, including CNS (Central Nervous System) infections and gastrointestinal infections, I recommend several different Transfer Factor formulas, to be taken together." 

Q.: How long does it usually take for a patient to experience positive results once they start taking Transfer Factor? 

Dr. Ryser: "My patients usually start to feel better within 3-6 months of beginning treatment with Transfer Factor. Dramatic results usually manifest in about one year, but we really begin to see positive changes in 5-6 months. It typically takes about a year of Transfer Factor treatment to really turn a patient around. I am specifically referring to chronically ill patients who have an average of 2-7 chronic infections that require treatment. The body’s cells regenerate every six months, and you need to give the body a chance to generate healthy cells before dramatic improvements in a patient’s overall health can emerge." 

Q.: What, if any, are the side effects or possible negative reactions that can occur with Transfer Factor therapy? 

Dr. Ryser: "The initial reactions to Transfer Factor a patient will experience are similar to a vaccination – but without, of course, exposure to the pathogen. The initial reaction typically includes flu-like symptoms, proportionate to the severity of a patient’s illness. These flu-like symptoms go away, but they prove that the immune system has been activated, and that it is working to suppress the body’s infections. 

Regarding the safety of Transfer Factor, I have never had a problem with negative side effects or adverse reactions. However, I am very cautious. I perform careful evaluations of a patient’s immune system. I check for viral leukemia, and so forth. I am very careful with cancer and autoimmune patients, with whom you must be cautious with regard to stimulating immune cells – this is particularly the case with Hodgkins Disease and Non-Hodgkins Lymphoma patients." 

(Note from Shirley: The Road To Better Health may begin with a Healing Crisis) 

Q.: What have you found to be the most positive benefits of Transfer Factor for your Chronic Fatigue Syndrome patients – what are the best results you have seen? 

Dr. Ryser: "The patient stops getting sick, and they don’t have any more infections. Their cognitive thinking clears up – no more brain fog. Their energy comes back – they can start doing more, and they can start walking and exercising again. They don’t suffer relapses. However, when a patient is doing well and they make the personal decision to stop taking Transfer Factor, I have seen relapses. I strongly recommend that a patient takes Transfer Factor for life – that is, it is a lifetime commitment for my chronically ill patients." 

*******************

Dr. Carol Ann Ryser, M.D., is a Board Certified Pediatrician, Board Certified Clinical Analyst, member of F.A.A.P., the American Medical Association, OHM (Orthomolecular Health Medicine), and the American Academy of Anti-Aging Medicine. The primary focus of Dr. Ryser’s medical practice is on the prevention of illness and disease. Since 1996, Dr. Ryser has been the Medical Director of Health Centers of America. Previously, she was Medical Director of the International Learning Centers, Director of Mid-American Treatment and Training, a staff member of the Gardner Medical Center, Consulting Staff Member of the Research Medical Center, Assistant Clinical Professor of Pediatrics at the University of Kansas Medical Center, Medical Director of the Children’s Rehabilitation Unit, University of Kansas Medical Center, Consultant to the Special Education Department for Orthopedically Handicapped Children, and a Consultant to the United States Air Force in Crete. Dr. Ryser has published and presented a number of papers in her area of expertise, appearing in such publications as The American Journal for Diseases of Children, the Journal of Neurology, Neurosurgery and Psychology and Pediatrics. Dr. Ryser has been recognized for her contributions in the fields of medicine, science, and mental health, as both a clinician and educator, by both professional and lay organizations. 

Transfer Factors are obtained through a proprietary, patented microfiltration process. The colostrum is collected within the first 24-48 hours of calving, then passed through the microfiltration machinery. The collection of transfer factors is from the excess colostrums, after a portion is given to the calf to protect it. That material is essentially free of all hormone additives. It is the cleanest time to collect milk for consumption and in this case, colostrum for providing transfer factors. The resultant filtrate is then pasteurized a second time and spray-dried into a fine powder. The powder then undergoes microbial testing for safety and a biological assay to ensure consistency and potency. A similar process is used on the egg yolks after they are separated from the whites. 
The Patent numbers are 4,816,563 and 6,468,534 (For Patent Information go on Transfer Factor Research site and once on Transfer Factor look for Transfer Factor Patent Information)

Both chickens and cows live mainly outside, where they eat off the ground, drink from shared water sources, endure varying weather conditions and contend with the challenges of communal living. This leaves them exposed to a variety of germs, bacteria and viruses, which their immune systems must battle and then remember in order for them to stay healthy. It's the heroic nature of their immune systems, needed for survival that makes them ideal donors for transfer factors. Because transfer factors can be shared safely and effectively from human to human, chicken to human or cow to human, either source alone offers excellent immune support. Combined, they offer the broadest and deepest range of immune support available. 

The following points illustrate the quality that goes into the sourcing of our transfer factors. 

1.  All of the dairy herds that produce colostrum for processing are from USDA Grade A dairy farms. As such the farm and milk must meet the standards of state and federal milk quality ordinances, including the Pasteurized Milk Ordinance (PMO). These state and federally inspected farms produce milk for the Grade A Fluid Milk Market. Milk from these farms is sold in the marketplace. 

2. It is unlawful to use antibiotics in lactating dairy cattle that will give rise to measureable levels of antimicrobial drugs. All tanker truckloads of milk are tested in all processing plants for such residues. Contaminated milk cannot be used for fluid or processing milk purposes. The financial penalties are severe and dairy producers have redundant management schemes in place to assure that residues do not occur. USDA and FDA statutes prohibit use of antibiotics as a feed supplement in lactating dairy cattle. 

3. Our inquiry revealed that the dairy farms that produce raw colostrum for processing do not use hormones intended to increase milk production, including rBST. 

4. All colostrum is pasteurized in a proprietary process to assure its microbial safety and quality. Moreover, the ultra-filtration process will remove all known microorganisms. Once dried the powder is tested for viable microbes. 

5. The agent associated with "Mad Cow Disease" (Bovine Spongiform Encephalopathy, (BSE)) has NOT been identified in the United States dairy herd. Additionally, there is no evidence of milk borne transmission in the English experience with BSE and the 36 Crutzfeldt-Jakobs Disease (CJD) patients. 

6. All other ingredients in the Transfer Factor product line are "Food Grade" as defined by the US FDA Center for Food Safety and Applied Nutrition and meet the US FDA GRAS (Generally Regarded As Safe) definition 
 

Question: What happens to the newborn calves who need that colostrum, when it is taken from them for 4life? Are mama cows allowed to roam in green pastures? Or are they in barns all year, like the premarin horses? 
4Life:  The cows are all free range cows and we obtain the colostrum after the calves have nursed for full time needed.  Cows produce more than enough colostrum. 

*********************************************************************************************
*
Quality Control Protocol: Herd Management
4Life’s management 

"It is of utmost importance to the management of 4Life; that we follow the most stringent quality control protocol in the care of the herds used to gather transfer factor and in the manufacturing process. The 4Life; manufacturing facility is pharmaceutical grade. David Lisonbee has been involved to some degree or another in quality manufacturing for more than two decades. In order to accomplish this protocol, we have contracted one of the foremost authorities in this area, Richard Bennett, Ph.D. 

Dr. Bennett has been an advisor to the FDA and to the USDA. He is the University of California Environmental Science Advisor in the North San Francisco Bay Region of California. He received his doctorate in Comparative Pathology at the world renowned UC Davis School of Veterinary Medicine. He has been a consultant to the National Research Council, the UC Davis Agricultural Issues Center, and to numerous national and local corporations. 

Our protocol for the herds is that the farmers do not give their cows any substances (including growth hormones), which have been known to be harmful to human beings. The herds are not placed near fields where pesticides or herbicides are used. Although it would be virtually impossible for any substance to make it through our stringent extraction and manufacturing process, this policy has been developed to address any concerns that our customers may have. There can be no antibiotics in the colostrum. If a cow is sick and has to have antibiotics, the cow is removed from the line until no antibiotics are found in its system. Any cow that shows any signs of illness is thoroughly checked out to eliminate any chance of mad cow disease or other serious conditions. Every batch is tested for contamination. 

While no antibiotics can be present in the cow’s colostrum, it is advantageous to the consumer of transfer factors that a cow, at some time in its life, has consumed antibiotics. Some of the greatest threats to the human race are the antibiotic-resistant strains of bacteria, which are now killing thousands of Americans. If the cow has been administered antibiotics and has come into contact with such pathogens, then the transfer factor could possibly communicate the memory of these mutated germs to our transfer factor. Remember, the purpose of transfer factor is to communicate immunity against pathogens the cow has been in contact with. This could be of major value to the consumer. The herds are scattered throughout the country so that we can gather transfer factor that has been exposed to a great variety of germs. Our quality control management keeps very close supervision over the herds. 

Another concern in the general public is mad cow disease. 4Life; has a very specific strategy to avoid mad cow disease. The key to avoiding mad cow disease or any other disease is to monitor the cows very carefully, avoid practices that expose the cows to the disease, and to test every batch of product as it is being processed. Our farmers are only from the United States. The cows are not, and never have been, fed any meat-containing products. One of our tests is performed on live mice. It would be very difficult for anything like mad cow disease to slip through our safety net. The supplement industry has much more stringent controls in place than does the food industry. Regularly E. coli and salmonella slip into our nation’s food supply. The real danger is with the food industry, not the nutrition industry, especially with a top-of-the-line manufacturer such as 4Life Research;. 

Although 4Life; is committed to being vigilant, there is evidence that BSE is not transmitted through milk type products. At a World Health Organization (WHO) Consultation organized in Geneva on April 2-3, 1996, a group of international experts reviewed the public health issues related to bovine spongiform encephalopathy (BSE) and the emergence of a new variant of Creutzfeldt-Jakob Disease (V-CJD). These scientists made the following statement: "Tests on milk from BSE-infected animals have not shown any BSE infectivity, and there is evidence from other animal and human spongiform encephalopathies to suggest that milk will not transmit these diseases. Milk and milk products, even in countries with high incidence of BSE, are therefore considered safe." 

*********************************************************************************************
*
Relieving Concerns about the "Mad Cow Disease" 
by Richard H. Bennett, Ph.D. - Expert in Infectious Disease Microbiology 

All 4Life Transfer Factor products are obtained from licensed Grade A dairies that are registered with and monitored by the United States Department of Agriculture (USDA).  Most importantly, science has demonstrated that mad cow disease is not transferred through milk or milk products.  Dr. William Hennen, Chief Scientific Officer of 4Life Research states, “We take great care to provide products that are safe and beneficial to our friends, customers and families.  BSE or mad cow disease has been known for more than ten years and we have evaluated all potential risk factors thoroughly.  There is no scientific evidence that milk or colostrum pose any risk for BSE transmission.” 

Over the last year, medical professionals and customers alike have raised questions about the safety of Transfer Factor products. Many of the questions are about TSE's (Transmissable Spongio encephalopathies). This concern arises from the events that have taken place in England over the last 14 years. 

In 1986 over 160,000 cases of bovine neurological disease were confirmed in sick cattle in Europe. The disease is called Bovine Spongiform Encephalopathy or BSE. The common linkage of this disease outbreak was the practice of feeding rendered animal waste products back to beef cattle. The infective agent is likely a Prion or a viral-like particle. The agents that cause TSE's have not been fully identified. Just the same the BSE agents withstand heat processing of normal cooking and pasteurization. Once ingested they have the ability to infect cells, especially neurological tissues, and reproduce themselves. 

The BSE agent is highly species specific as it infects the bovine almost exclusively. The concern about BSE and human health arose from a statistical linkage that suggested that a variant of the BSE agent was able to cause the human equivalent of BSE called Creutzfeldt-Jakob Disease or CJD. CJD has a genetic predisposition component and occurs worldwide at a rate of 1 per million persons. CJD has been linked to the use of Human Growth Hormone (HGH) use and transplantation of neurological tissue. 

In England a variant form of CJD was identified in 14 patients as of 1996. In contrast to typical CJD, this variant affected young patients. Rigorous scientific review concluded that no definite link between BSE and the CDJ variant could be established. Circumstantial evidence suggested that consumption of meat containing the BSE agent was the likely cause. Thousands of English and European consumers were likely exposed, yet only 14 human cases have been confirmed. Milk and dairy products did not appear to be a linkage to the disease and are considered safe by UK authorities. 

There are TSE's in other animals in the US, including cats, mink, deer, elk, sheep and goats. There is no evidence of horizontal transmission to humans from these species. 

In August of 1997 the FDA instituted regulations that prohibit the refeeding of most animal proteins to cattle and other ruminants. Feeding animal protein to milk cows has never been recommended and has not been the practice of the dairy producer.

In summary, we should have great confidence that all colostrum and bovine sources of thymus protein are not contaminated with the BSE agent. The programs and regulations currently in place will work effectively to ensure product safety for 4Life products derived from animal sources. 

References 

Sources: WHO Fact Sheet No. 133, Bovine Spongiform Encephalopathy, www.who.int/inf-fs/en/fact113.html

USDA, APHIS, Bovine Spongiform Encephalopathy, www.aphis.usda.gov/oa/bse 

If your question is not answered by utilizing this web page, please contact the 4Life Product Support department